Cartesian Therapeutics, Inc.
RNAC • NASDAQ
Cartesian Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carsten Brunn, with a market cap of $163.8M.
Market Cap$163.8M
Employees38.0
CEOCarsten Brunn
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Cartesian Therapeutics, Inc. FAQ
Common questions about Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $261.9K.
Cartesian Therapeutics, Inc. has approximately 38 employees.